TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages

Nucleic Acids Research

Volumn 36, Issue 9, 2008, Pages 3118-3127

  Sevilimedu, Aarti ^a   Shi, Hua ^a,b   Lis, John T ^a  

^a Department of Obstetrics Gynecology   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; OLIGONUCLEOTIDE; RNA APTAMER; RNA POLYMERASE II; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR IIB; TRANSCRIPTION FACTOR IIB APTAMER;

ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME SPECIFICITY; FUNGAL GENETICS; GENE TRANSCRIPTION INHIBITION; GENETIC TRANSCRIPTION; IN VITRO STUDY; NONHUMAN; PREINITIATION COMPLEX FORMATION; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROTEIN INTERACTION; SACCHAROMYCES CEREVISIAE;

APTAMERS, NUCLEOTIDE; BINDING SITES; FUNGAL PROTEINS; PROTEIN FOOTPRINTING; SELEX APTAMER TECHNIQUE; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION, GENETIC; YEASTS;

EUKARYOTA;

EID: 44349158997     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn163     Document Type: Article

References (36)

1. Famulok,M. and Mayer,G. (2005) Intramers and aptamers: Applications in protein-function analyses and potential for drug screening. Chembiochem, 6, 19-26.
2. Tuerk,C. and Gold,L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 249, 505-510.
3. Ellington,A.D. and Szostak,J.W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature, 346, 818-822.
4. Gold,L., Polisky,B., Uhlenbeck,O. and Yarus,M. (1995) Diversity of oligonucleotide functions. Annu. Rev. Biochem., 64, 763-797.
5. Famulok,M., Blind,M. and Mayer,G. (2001) Intramners as promising new tools in functional proteomics. Chem. Biol., 8, 931-939.
6. Hahn,S. (2004) Structure and mechanism of the RNA polymerase II transcription machinery. Nat. Struct. Mol. Biol., 11, 394-403.
7. Thomas,M.C. and Chiang,C.M. (2006) The general transcription machinery and general cofactors. Crit. Rev. Biochem. Mol. Biol., 41, 105-178.
8. Deng,W. and Roberts,S.G. (2007) TFIIB and the regulation of transcription by RNA polymerase II. Chromosoma, 116, 417-429.
9. Yudkovsky,N., Ranish,J.A. and Hahn,S. (2000) A transcription reinitiation intermediate that is stabilized by activator. Nature, 408, 225-229.
10. Shi,H., Fan,X., Sevilimedu,A. and Lis,J.T. (2007) RNA aptamers directed to discrete functional sites on a single protein structural domain. Proc. Natl Acad. Sci. USA, 104, 3742-3746.
11. Fan,X., Shi,H., Adelman,K. and Lis,J.T. (2004) Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes. Proc. Natl Acad. Sci. USA, 101, 6934-6939.
12. Pinto,I., Ware,D.E. and Hampsey,M. (1992) The yeast SUA7 gene encodes a homolog of human transcription factor TFIIB and is required for normal start site selection in vivo. Cell, 68, 977-988.
13. Wu,W.H., Pinto,I., Chen,B.S. and Hampsey,M. (1999) Mutational analysis of yeast TFIIB. A functional relationship between Ssu72 and Sub1/Tsp1 defined by allele-specific interactions with TFIIB. Genetics, 153, 643-652.
14. Grossmann,J.G., Sharff,A.J., O'Hare,P. and Luisi,B. (2001) Molecular shapes of transcription factors TFIIB and VP16 in solution: Implications for recognition. Biochemistry, 40, 6267-6274.
15. Hori,R. and Carey,M. (1997) Protease footprinting analysis of ternary complex formation by human TFIIA. J. Biol. Chem., 272, 1180-1117.
16. Shi,H., Hoffman,B.E. and Lis,J.T. (1997) A specific RNA hairpin loop structure binds the RNA recognition motifs of the drosophila SR protein B52. Mol. Cell. Biol., 17, 2649-2657.
17. Zhao,X., Shi,H., Sevilimedu,A., Liachko,N., Nelson,H.C. and Lis,J.T. (2006) An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucleic Acids Res., 34, 3755-3761.
18. Schagger,H. (2006) Tricine-SDS-PAGE. Nat. Protoc., 1, 16-22.
19. Thompson,J.D., Higgins,D.G. and Gibson,T.J. (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680.
20. Pardee,T.S., Bangur,C.S. and Ponticeiii,A.S. (1998) The N-terminal region of yeast TFIIB contains two adjacent functional domains involved in stable RNA polymerase II binding and transcription start site selection. J. Biol. Chem., 273, 17859-17864.
21. Buratowski,S., Hahn,S., Guarente,L. and Sharp,P.A. (1989) Five intermediate complexes in transcription initiation by RNA polymerase II. Cell, 56, 549-561.
22. Espinoza,C.A., Allen,T.A., Hieb,A.R., Kugel,J.F. and Goodrich,J.A. (2004) B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat. Struct. Mol. Biol. 11, 822-829.
23. Hori,R., Pyo,S. and Carcy,M. (1995) Protease footprinting reveals a surface on transcription factor TFIIB that serves as an interface for activators and coactivators. Proc. Natl Acad. Sci. USA, 92, 6047-6051.
24. Bangur,C.S. Pardee,T.S. and Ponticelli,A.S. (1997) Mutational analysis of the d1/E1 core helices and the conserved N-terminal region of yeast transcription factor IIB (TFIIB): Identification of an N-terminal mutant that stabilizes TATA-binding protein-TFIIB-DNA complexes. Mol. Cell. Biol., 17, 6784-6793.
25. Roberts,S.G., Ha,I., Maldonado,E., Reinberg,D. and Green,M.R. (1993) Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature, 363, 741-744.
26. White,R.R., Sullenger,B.A.and Rusconi,C.P. (2000) Developing aptamers into therapeutics. J. Clin. Invest., 106, 929-934.
27. Gold.L. (1995) Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem., 270, 13581-31584.
28. Miyakawa,S., Fujiwara,M. and Nakamura,Y. (2006 Aptamer therapeutics. Tanpakushitsu Kakusan Koso, 51, 2521-2527.
29. Que-Gewirth,N.S. and Sullenger,B.A. (2007) Gene therapy progress and prospects: RNA aptamers. Gene Ther., 14, 283-291.
30. Eckstein,F. (2007) The versatility of oligonucleotides as potential therapeutics. Expert Opin. Biol. Ther., 7, 1021-1034.
31. Shi,H., Hoffman,B.E. and Lis,J.T. (1999) RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl Acad. Sci. USA, 96, 10033-10038.
32. Carothers,J.M., Oestreich,S.C., Davis,J.H. and Szostak, J.W. (2004) Informational complexity and functional activity of RNA structures. J. Am. Chem. Soc., 126, 5130-5137.
33. XayaphoumminemA., Bucher,T. and Isambert,H. (2005.) Kinefold web server for RNA/DNA folding path and structure prediction including pseudoknots and knots. Nucleic Acids Res., 33, W605-W610.
34. Carothers,J.M., Oestreich,S.C. and Szostak,J.W. 2006) Aptamers selected for higher-affinity binding are not more specific for the target ligand. J. Am. Chem. Soc., 128, 7929-7937.
35. Roberts,S.G. and Green,M.R. (1994) Activator-induced conformational change in general transcription factor TFIIB. Nature, 371, 717-720.
36. Burke,D.H. and Nickens,D.G. (2002) Expressing RNA aptamers inside cells to reveal proteome and ribonome function. Brief Funct. Genomic Proteomic., 1, 169-188.